InVivo has signed an agreement to acquire, through its holding company InVivo¬†AgroSciences, Bioline, a subsidiary of Syngenta specialized in the production and marketing¬†of biological control agents, and in particular macro-organisms active against insects¬†pests in fruits, vegetable and flower crops. By joining forces, Bioline and Biotop, a longstanding¬†InVivo subsidiary working in biological pest control, will become a truly global¬†player in a high-potential and fast-growing market.
Investing in high-potential businesses to create French champions with critical mass is one of the clearly stated ambitions¬†in the ‚Äú2025 by InVivo‚Äù strategic plan. On the same level as digital agriculture, biosolutions* are among the main future¬†paths that the InVivo group intends to explore as part of its drive to produce more and better.
Strengthened by its long-standing know-how with its subsidiary Biotop, the acquisition of Bioline will enable InVivo to¬†build the capacities required to develop a significant activity in biosolutions.
The growth of this USD 2.8 billion market is estimated at 10% a year for the coming ten years.
Bioline has two production sites in the UK and USA. The company is highly present in the macro-organisms market and¬†more specifically in mites in northern Europe used against predatory insects in greenhouse crops. Biotop has a bioplant¬†in the Dr√¥me department in France, specialised notably in the production of ephestia eggs (used for raising auxiliaries)¬†and trichogramma (micro-wasps that fight against corn borers).
The two companies make a highly complementary fit through their expertise in arable crops and specialised crops,¬†their geographical presence in France and internationally, and their portfolio of macro-organisms. Together they will¬†employ 135 people.
Commenting, Thierry Blandini√®res, CEO of the InVivo group, said: ‚ÄúThe acquisition of Bioline demonstrates InVivo‚Äôs¬†strategic ambition to invest in high-potential solutions that will enable agriculture to produce more in response to the¬†world‚Äôs demographic issues while ensuring the greatest respect for natural balances.‚Äù
Alexander Tokarz, Head of Global Crops and Assets at Syngenta said: ‚ÄúBioline is a strongly performing business with¬†good potential for further growth. Due to its highly specialized nature, we are convinced that Bioline‚Äôs potential will be¬†better realized in combination with InVivo, who are already well positioned in this market. Syngenta remains fully committed¬†to the broader field of biological solutions complementing our innovative crop protection and traits portfolio¬†with enhanced spectrum and differentiated modes of actions.‚Äù